EX-23.1 4 ipsc-20241231xex23d1.htm EX-23.1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the following Registration Statements:

1)Registration Statement (Form S-3, No. 333-280310) of Century Therapeutics, Inc.,
2)Registration Statement (Form S-3, No. 333-279422) of Century Therapeutics, Inc.,
3)Registration Statement (Form S-3 No. 333-265975) of Century Therapeutics, Inc.,
4)Registration Statement (Form S-8, No. 333-277930) pertaining to the 2021 Equity Incentive Plan of Century Therapeutics, Inc.,
5)Registration Statement (Form S-8 No. 333-270649) pertaining to the 2021 Equity Incentive Plan of Century Therapeutics, Inc.,
6)Registration Statement (Form S-8 No. 333-263666) pertaining to the 2021 Equity Incentive Plan and 2021 Employee Stock Purchase Plan of Century Therapeutics, Inc.,
7)Registration Statement (Form S-8 No. 333-257644) pertaining to the 2018 Stock Option and Grant Plan, 2021 Equity Incentive Plan, and the 2021 Employee Stock Purchase Plan of Century Therapeutics, Inc.,

​

of our report dated March 19, 2025, with respect to the consolidated financial statements of Century Therapeutics, Inc. included in this Annual Report (Form 10-K) of Century Therapeutics, Inc. for the year ended December 31, 2024.

​

/s/ Ernst & Young LLP

​

Philadelphia, Pennsylvania

March 19, 2025